Cargando…
Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3
The success of CD8(+) T cell-based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and the possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that peptides generated in the nucleus during a pioneer...
Autores principales: | Boulpicante, Mathilde, Darrigrand, Romain, Pierson, Alison, Salgues, Valérie, Rouillon, Marine, Gaudineau, Benoit, Khaled, Mehdi, Cattaneo, Angela, Bachi, Angela, Cascio, Paolo, Apcher, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458623/ https://www.ncbi.nlm.nih.gov/pubmed/32923122 http://dx.doi.org/10.1080/2162402X.2020.1761205 |
Ejemplares similares
-
Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens
por: Darrigrand, Romain, et al.
Publicado: (2021) -
The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
por: Yazgili, Ayse Seda, et al.
Publicado: (2022) -
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
por: Lin, Chiou-Feng, et al.
Publicado: (2017) -
SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
por: Son, Seung Han, et al.
Publicado: (2023) -
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
por: Passarelli, Anna, et al.
Publicado: (2017)